Kelly Londy
Direktor/Vorstandsmitglied bei CMR Surgical Ltd.
Vermögen: 21 647 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Kelly Londy
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Medical Specialties | 24 | |
CMR Surgical Ltd.
CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom.
9
| Holding Company | Medical Specialties | 9 |
Public Company | Medical Specialties | 6 | |
Lumicell, Inc.
Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Lumicell, Inc. develops and markets image-guided cancer surgery solutions. It offers Lumicell System, designed to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery. The company was founded by Linda G. Griffith, David G. Kirsch, Jorge M. Ferrer, Ralph Weissleder, W. David Lee, Andrey J. Zarur, and Moungi G. Bawendi in 2008 and is headquartered in Wellesley, MA.
2
| Holding Company | Electronic Equipment/Instruments | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kelly Londy
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
IMMUCOR, INC. | Medical Specialties | President | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | President Corporate Officer/Principal Corporate Officer/Principal | |
AMO Manufacturing USA LLC
AMO Manufacturing USA LLC Medical SpecialtiesHealth Technology AMO Manufacturing USA LLC engages in the design, develop and manufacture of excimer refractive surgical systems. It is designed to re-contour the front surface of the cornea of the human eye. The company was founded in 1988 and is headquartered in Santa Clara, CA. | Medical Specialties | Director of Finance/CFO Director of Finance/CFO | |
MORGAN STANLEY | Investment Managers | Corporate Officer/Principal | |
Conceptus, Inc.
Conceptus, Inc. Medical SpecialtiesHealth Technology Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA. | Medical Specialties | Director of Finance/CFO Comptroller/Controller/Auditor | |
REVVITY, INC. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
SANDVIK AB | Trucks/Construction/Farm Machinery | Director of Finance/CFO | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
McNeil Consumer Healthcare (Canada)
McNeil Consumer Healthcare (Canada) Household/Personal CareConsumer Non-Durables McNeil Consumer Healthcare manufactures medicals products. It offers headache and muscle pain, arthritis pain, sinus, cold, flu, sleep and pain products as well as products for children and infants. The company is headquartered in Guelph, Canada. | Household/Personal Care | President President | |
ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
GUARDANT HEALTH, INC. | Medical/Nursing Services | Director of Finance/CFO General Counsel | |
ELECTROLUX AB | Electronics/Appliances | Director of Finance/CFO Public Communications Contact | |
Seco Tools AB
Seco Tools AB Tools & HardwareConsumer Durables Seco Tools AB manufactures and supplies carbide cutting tools and associated equipment. It provides metal cutting solutions for milling, stationary tools, hole making and tooling systems. The company was founded in 1932 and is headquartered in Fagersta, Sweden. | Tools & Hardware | Director of Finance/CFO | |
OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Masters Business Admin Graduate Degree | |
Amoun Pharmaceutical Co. SAE
Amoun Pharmaceutical Co. SAE Pharmaceuticals: MajorHealth Technology Amoun Pharmaceutical Co. SAE manufactures and distributes human and veterinary pharmaceutical products and food supplements. The firm’s products include analgesics, anti-infectives, cardiovascular and gastrointestinal drugs and drugs for anesthesia, genito-urinary disorders, and respiratory systems. The company was founded by Sarwat Bassily in 1976 and is headquartered in Cairo, Egypt. | Pharmaceuticals: Major | Director/Board Member | |
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Indiana University-Purdue University | College/University | Undergraduate Degree | |
Yale University | College/University | Graduate Degree Graduate Degree | |
University of Uppsala | College/University | Undergraduate Degree | |
ABLYNX | Biotechnology | Director/Board Member | |
University of Stockholm | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
TomoTherapy, Inc.
TomoTherapy, Inc. Medical SpecialtiesHealth Technology TomoTherapy, Inc. manufactures and provides radiation treatment systems for advanced radiation therapy. It provides radiation treatment services for cancer patients with its TomoTherapy Hi·Art System, which changes the intensity of the radiation beam so that it adapts to the shape of the tumor. The firm's system focuses on killing cancer cells while sparing healthy tissue. The company was founded by Thomas Rockwell Mackie and Paul J. Reckwerdt in 1997 and is headquartered in Madison, WI. | Medical Specialties | Chief Executive Officer Director of Finance/CFO Chief Executive Officer General Counsel | |
Royal Institute of Technology | College/University | Graduate Degree Graduate Degree | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
ABB Robotics AB
ABB Robotics AB Miscellaneous Commercial ServicesCommercial Services Part of ABB Ltd., ABB Robotics AB is a Swedish company that provides automated picking, packing and palletising robots. The company is based in Västerås, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Healthcare Leadership Council
Healthcare Leadership Council Medical/Nursing ServicesHealth Services Healthcare Leadership Council operates as a organization focusing on the provision of a healthcare system. The company is headquartered in Washington, DC. | Medical/Nursing Services | Corporate Officer/Principal | |
Capital Group Private Markets, Inc UK Branch | Investment Managers | Private Equity Investor | |
Conceptus SAS
Conceptus SAS Medical SpecialtiesHealth Technology Conceptus SAS is a subsidiary of Conceptus Inc. Conceptus is engaged in the design, development, promotion and distribution of innovative medical products for use in the field of women's health. The company Conceptus SAS is headquartered in Versailles France. | Medical Specialties | Director of Finance/CFO Comptroller/Controller/Auditor | |
ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member | |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
BIOTALYS NV | Chemicals: Agricultural | Director/Board Member | |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer | |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Creabilis SA | Director/Board Member | ||
GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member | |
DNA Script SAS
DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Intrinsic Capital Partners
Intrinsic Capital Partners Investment ManagersFinance Intrinsic Capital Partners is a private equity/venture capital firm founded by Gerald Stahlecker, Cornelius Merlini, and Howard Goodwin. The firm is headquartered in Conshohocken, Pennsylvania. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
Noema Pharma AG
Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member | |
MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Vereinigte Staaten | 18 |
Schweden | 9 |
Schweiz | 6 |
Vereinigtes Königreich | 6 |
Frankreich | 6 |
Sektoral
Health Technology | 31 |
Consumer Services | 7 |
Finance | 5 |
Health Services | 3 |
Consumer Durables | 3 |
Operativ
Director/Board Member | 126 |
Corporate Officer/Principal | 50 |
Independent Dir/Board Member | 40 |
President | 34 |
Chief Executive Officer | 33 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Tony Vernon | 34 |
Catherine Moukheibir | 29 |
William McComb | 19 |
Peter Fine | 19 |
Mike Ruettgers | 18 |
Emad Rizk | 16 |
Richard R. Pettingill | 14 |
Tomas Eliasson | 13 |
Euan Stuart Thomson | 12 |
Mark Hair | 10 |
Supratim Bose | 10 |
Chris A. Raanes | 10 |
Derek A. Bertocci | 10 |
Darren J. Milliken | 9 |
Kevin Waters | 9 |
- Börse
- Insiders
- Kelly Londy
- Unternehmensverbindungen